{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:25:36Z","timestamp":1794932736084,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vaccine.2022.07.041","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T16:17:09Z","timestamp":1660148229000},"page":"5504-5512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0014-2602","authenticated-orcid":false,"given":"Haruka","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhim","family":"Gopal Dhoubhadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Sando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitsugu","family":"Furumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norichika","family":"Asoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makito","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Aoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugihiro","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konosuke","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.07.041_b0005","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12325-020-01248-7","article-title":"Burden of community-acquired pneumonia and unmet clinical needs","volume":"37","author":"Ferreira-Coimbra","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.vaccine.2022.07.041_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122247","article-title":"The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study","volume":"10","author":"Morimoto","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.07.041_b0015","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/1471-2334-14-534","article-title":"Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study","volume":"14","author":"Fukuyama","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2022.07.041_b0020","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","article-title":"Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia","volume":"188","author":"Shindo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2022.07.041_b0025","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268819000657","article-title":"Decreasing case fatality rate following invasive pneumococcal disease, North East England, 2006\u20132016","volume":"147","author":"Houseman","year":"2019","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2022.07.041_b0030","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.3201\/eid2610.191531","article-title":"Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in adults, Japan, 2013\u20132017","volume":"26","author":"Shimbashi","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.07.041_b0035","unstructured":"Sunagawa T, Kozuki E, Fukusumi M, Takahashi T. Analysis of the Infectious Disease Outbreak Surveillance of Invasive Pneumococcal Infections from 2013 to 2017. Available from: https:\/\/mhlw-grants.niph.go.jp\/system\/files\/2017\/172111\/201718007A_upload\/201718007A0004.pdf [accessed Feb 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0040","unstructured":"Epidemiology of pediatric and adult invacive pnuemococcal disease in Japan. Available from: https:\/\/ipd-information.com\/?page_id=49 [accessed June 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0045","unstructured":"Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP). Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/index.html [accessed Feb 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0050","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis","volume":"5","author":"Shiri","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2022.07.041_b0055","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2017.04.032","article-title":"Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: a systematic review of the literature","volume":"35","author":"Tsaban","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.041_b0060","unstructured":"National Institute of Infectious Diseases. Fact sheet of the 23-valent pneumococcal polysaccharide vaccine 2018. Available from: https:\/\/www.mhlw.go.jp\/file\/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka\/0000184910_1.pdf [accessed Feb 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0065","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1016\/j.vaccine.2015.07.069","article-title":"Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: effects of the seven-valent pneumococcal conjugate vaccine","volume":"33","author":"Suga","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.041_b0070","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3201\/eid2411.180326","article-title":"Effects of pneumococcal conjugate vaccine on genotypic penicillin resistance and serotype changes, Japan, 2010\u20132017","volume":"24","author":"Ubukata","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.07.041_b0075","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.vaccine.2019.04.009","article-title":"Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)","volume":"37","author":"Sando","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.041_b0080","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jiac.2019.07.007","article-title":"Distribution and annual changes in the proportion of Streptococcus pneumoniae serotypes in Japanese adults with pneumococcal pneumonia from 2011 to 2017","volume":"25","author":"Noguchi","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2022.07.041_b0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jiac.2017.01.008","article-title":"The distribution and annual changes in the Streptococcus pneumoniae serotypes in adult Japanese patients with pneumococcal pneumonia from 2011 to 2015","volume":"23","author":"Akata","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2022.07.041_b0090","doi-asserted-by":"crossref","unstructured":"Kobayashi MFJ, Gierke R, et al. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:109\u201317. Doi: 10.15585\/mmwr.mm7104a1.","DOI":"10.15585\/mmwr.mm7104a1"},{"key":"10.1016\/j.vaccine.2022.07.041_b0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(17)30049-X","article-title":"Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study","volume":"17","author":"Suzuki","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.07.041_b0100","unstructured":"Ministry of Health, Labour and Welfare. Number of people administered routine vaccinations. Available from: https:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html [accessed Feb 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0105","unstructured":"Murakami Y, Nishiwaki Y, Kanazu SI, Oba M, Watanabe A. A nationwide survey of PPSV23 vaccine coverage rates and their related factors among the elderly in Japan, 2016. Nihon Koshu Eisei Zasshi. 2018;65:20\u201324. doi: 10.11236\/jph.65.1_20."},{"key":"10.1016\/j.vaccine.2022.07.041_b0110","unstructured":"Ministry of Health, Labour and Welfare. Sciences Council (Subcommittee on Immunization and Vaccination, Subcommittee on Adverse Reactions). Available from: https:\/\/www.mhlw.go.jp\/stf\/shingi\/shingi-kousei_284075.html [accessed Feb 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0115","unstructured":"Statistics Bureau of Japan. Population Estimates. Available from: https:\/\/www.stat.go.jp\/english\/index.html [accessed Feb 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0120","unstructured":"Centers for Disease Control and Prevention. Streptococcus Laboratory. Available from: https:\/\/www.cdc.gov\/streplab\/index.html [accessed Feb 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0125","unstructured":"SSI Diagnostica. IMMULEX\u2122 PNEUMOTEST. Available from: https:\/\/ssidiagnostica.com\/wp-content\/uploads\/2021\/03\/BROCHURE-Immulex-Pneumotest-50567-4.pdf [accessed June 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0130","unstructured":"World Health Organization. Considerations for Pneumococcal Conjugate Vaccine (PCV) Product Choice 2021. Available from: https:\/\/www.google.co.jp\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjJ1qTqu8L4AhWKJaYKHbgOAE0QFnoECAQQAQ&url=https%3A%2F%2Fapps.who.int%2Firis%2Frest%2Fbitstreams%2F1368419%2Fretrieve&usg=AOvVaw1IfqNW5eIgVanvYtSLm0gG [accessed June 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/thx.2006.067371","article-title":"The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia","volume":"62","author":"Barlow","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2022.07.041_b0140","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1056\/NEJMc0904844","article-title":"Holiday spikes in pneumococcal disease among older adults","volume":"361","author":"Walter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.07.041_b0145","unstructured":"Advisory Committee on Immunization Practices. Current Epidemiology of Pneumococcal Disease and Pneumococcal Vaccine Coverage among Adults, United States. 2021. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-02\/24-25\/02-Pneumococcal-Gierke.pdf [accessed Feb 10, 2022]."},{"key":"10.1016\/j.vaccine.2022.07.041_b0150","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1128\/AAC.03344-14","article-title":"Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States","volume":"58","author":"Richter","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2022.07.041_b0155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jinf.2020.07.035","article-title":"Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009\u20132017","volume":"81","author":"Suaya","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2022.07.041_b0160","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1016\/j.vaccine.2018.06.018","article-title":"Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010\u20132016","volume":"36","author":"Demczuk","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.041_b0165","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1016\/j.vaccine.2019.05.003","article-title":"Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)","volume":"37","author":"LeBlanc","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.041_b0170","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.07.041_b0175","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa043","article-title":"Characteristics of invasive pneumococcal disease (IPD) caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in England; prospective observational cohort study, 2014\u201318","author":"Amin-Chowdhury","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.07.041_b0180","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1183\/09031936.00183614","article-title":"Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia","volume":"45","author":"Rodrigo","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2022.07.041_b0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013\u201318","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2022.07.041_b0190","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10096-016-2868-5","article-title":"Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children","volume":"36","author":"Hays","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2022.07.041_b0195","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1016\/j.vaccine.2019.09.065","article-title":"Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: emergence of drug-resistant non-vaccine serotypes","volume":"38","author":"Kim","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.041_b0200","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab307","article-title":"The evolution and distribution of pneumococcal serotypes in adults hospitalized with community acquired pneumonia in Spain using serotype specific urinary antigen detection test: the CAPA study, 2011\u20132018","author":"Torres","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.07.041_b0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/thx.2009.123612","article-title":"Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes","volume":"65","author":"Garcia-Vidal","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2022.07.041_b0210","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2019.04.087","article-title":"Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia","volume":"37","author":"Isturiz","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.041_b0215","doi-asserted-by":"crossref","first-page":"e01874","DOI":"10.1128\/JCM.01874-17","article-title":"Accuracy of high-throughput nanofluidic PCR-based pneumococcal serotyping and quantification assays using sputum samples for diagnosing vaccine serotype pneumococcal pneumonia: analyses by composite diagnostic standards and bayesian latent class models","volume":"56","author":"Kakiuchi","year":"2018","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:16:03Z","timestamp":1759403763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22009380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":43,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0264410X22009380"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}